We are live on ! Find out more
PPH icon

VanEck Pharmaceutical ETF
PPH

138 hedge funds and large institutions have $417M invested in VanEck Pharmaceutical ETF in 2024 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 39 increasing their positions, 34 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

322% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 9

227% more call options, than puts

Call options by funds: $1.63M | Put options by funds: $499K

25% more funds holding

Funds holding: 110 → 138 (+28)

15% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 34

6% more capital invested

Capital invested by funds: $394M → $417M (+$23.4M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

11.47% less ownership

Funds ownership: 88.94% → 77.47% (-11%)

Holders
138
Holders Change
+28
Holders Change %
+25.45%
% of All Funds
1.99%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
38
Increased
39
Reduced
34
Closed
9
Calls
$1.63M
Puts
$499K
Net Calls
+$1.13M
Net Calls Change
+$4.11M

Top Buyers

Rank Fund Capital Flow
1
JSAM
J. Safra Asset Management
New York
+$6.09M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$3.58M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$3.27M
4
BHB
Bank Hapoalim BM
Israel
+$3.09M
5
Jane Street
Jane Street
New York
+$3.05M

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$19M
2
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$8.76M
3
VV
Verity & Verity
South Carolina
-$7.77M
4
Morgan Stanley
Morgan Stanley
New York
-$6.41M
5
VAS
Valicenti Advisory Services
New York
-$4.96M
Name Holding Trade Value Shares
Change 		Change in
Stake
BCI
26
Brinker Capital Investments
Pennsylvania
$2.99M -$161K -1,844 -5%
OPS
27
Orion Portfolio Solutions
Nebraska
$2.99M -$161K -1,844 -5%
Ameriprise
28
Ameriprise
Minnesota
$2.83M +$587K +6,705 +27%
KWM
29
Kingsview Wealth Management
Oregon
$2.74M +$2.42M +27,687 +1,104%
Cetera Investment Advisers
30
Cetera Investment Advisers
Illinois
$2.38M +$1.74M +19,912 +316%
AGC
31
Aspen Grove Capital
Colorado
$2.29M -$88 -1 -0%
Royal Bank of Canada
32
Royal Bank of Canada
Ontario, Canada
$2.19M -$274K -3,135 -12%
Commonwealth Equity Services
33
Commonwealth Equity Services
Massachusetts
$1.93M +$583K +6,655 +45%
EH
34
Equitable Holdings
New York
$1.91M -$619K -7,072 -25%
BCM
35
Beck Capital Management
Texas
$1.9M +$78.5K +897 +4%
IMC Chicago
36
IMC Chicago
Illinois
$1.89M +$1.83M +20,854 New
CAN
37
Cetera Advisor Networks
California
$1.71M +$373K +4,256 +29%
GCP
38
GSA Capital Partners
United Kingdom
$1.69M +$766K +8,744 +89%
RJFSA
39
Raymond James Financial Services Advisors
Florida
$1.61M -$31.7K -362 -2%
VAS
40
Valicenti Advisory Services
New York
$1.58M -$4.96M -56,686 -77%
AWS
41
Atria Wealth Solutions
New York
$1.57M +$1.19M +13,642 +367%
UBS Group
42
UBS Group
Switzerland
$1.42M +$181K +2,067 +15%
HSBC Holdings
43
HSBC Holdings
United Kingdom
$1.39M +$1.34M +15,322 New
Mirae Asset Global Investments
44
Mirae Asset Global Investments
South Korea
$1.31M +$1.27M +14,490 New
Renaissance Technologies
45
Renaissance Technologies
New York
$1.27M -$490K -5,602 -29%
National Bank of Canada
46
National Bank of Canada
Quebec, Canada
$1.25M +$30.9K +353 +3%
OC
47
Oppenheimer & Co
New York
$1.24M +$516K +5,899 +76%
Millennium Management
48
Millennium Management
New York
$1.15M +$1.11M +12,711 New
PPG
49
Peak Planning Group
Colorado
$1.1M +$12.8K +146 +1%
FFM
50
Fullerton Fund Management
Singapore
$1.1M +$1.06M +12,099 New
1
2
3 4 5

PPH Hedge Fund Activity: Q1 2024 in Review

138 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in VanEck Pharmaceutical ETF (PPH) for Q1 2024, worth a combined $417M — up 5.9% from $394M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new PPH positions and 9 closed out — a net gain of 29 holders — while 39 added to existing stakes and 34 trimmed.

The largest buyer was J. Safra Asset Management, opening a new position worth an estimated $6.09M. The largest seller was Bank of America, cutting an estimated $19M.

  • 138 institutional investors held VanEck Pharmaceutical ETF (PPH) as of Q1 2024, up from 110 in Q4 2023.
  • Funds reported $417M of VanEck Pharmaceutical ETF stock for Q1 2024, up 5.9% quarter-over-quarter.
  • 38 funds opened new VanEck Pharmaceutical ETF positions in Q1 2024 and 9 closed out, a net change of +29 holders.
  • The largest VanEck Pharmaceutical ETF buyer in Q1 2024 was J. Safra Asset Management, an estimated $6.09M added.
  • The largest VanEck Pharmaceutical ETF seller in Q1 2024 was Bank of America, an estimated $19M sold.

Based on aggregated 13F filings for Q1 2024.